Program Designed to Increase Use of Recommended Medication Therapy by Connecting with Providers in Workflow LOUISVILLE, Ky. and ARLINGTON, Va.

Here's Why Humana (HUM) is a Strong Value Stock

10:40am, Tuesday, 12'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bragar Eagel & Squire, P.C. Litigation Attorney  Brandon Walker  Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance ac

Humana (HUM) Q2 Revenue Rises 10%

05:43am, Thursday, 31'st Jul 2025
Humana (HUM) Q2 Revenue Rises 10%
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.

Humana Inc. (HUM) Q2 2025 Earnings Call Transcript

01:36pm, Wednesday, 30'th Jul 2025
Humana Inc. (NYSE:HUM ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Celeste Marie Mellet - Chief Financial Officer George Renaudin - President of Insurance James A.
U.S. equities were mixed at midday as the market responded to the U.S. economy growing more than expected in the second quarter while waiting for today's decision by the Federal Reserve on interest ra
Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street est
As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. HUM is adapting to these changes through strategic adjustments. This adaptability is reflected in their

Humana (HUM) Q2 Earnings Lag Estimates

08:16am, Wednesday, 30'th Jul 2025
Humana (HUM) came out with quarterly earnings of $6.27 per share, missing the Zacks Consensus Estimate of $6.32 per share. This compares to earnings of $6.96 per share a year ago.
Humana's stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.
Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in p
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE